Understanding rheumatic and musculoskeletal diseases (RMDs) is an understandably tall order for the lay public, what with the huge number of conditions and the complex—and often little understood—processes involved. Now, a working group of the European League Against Rheumatism (EULAR) and the ACR has set out to try to correct this problem with a definition…
The ACR’s Experts on Call Program Connects Journalists with Experts
Rheumatological diseases can be complex, so how can those within the specialty help ensure information about rheumatology shared by the media is accurate? Cue the ACR/ARHP Experts on Call program, which is designed to connect rheumatology health professionals with journalists looking for subject matter experts. Experts on Call is managed by the ACR’s Public Relations…
The ACR & Simple Tasks Announce First-Ever Rheumatic Disease Awareness Month
Until now, rheumatic diseases have never had a unified national health observance to bring stakeholders—physicians, patients, patient advocacy groups, government, pharmaceutical companies and the public—together. This September, the ACR and Simple Tasks are launching Rheumatic Disease Awareness Month to improve the public’s understanding and awareness of the symptoms, risk factors, treatment options, personal and economic impact, and lifestyle and healthcare challenges associated with rheumatic disease…
Advocating with You—Grassroots Advocacy: Media Outreach 101
Rheumatologists must speak for themselves and their patients, because no one else will speak for us. Advocacy is necessary to educate elected officials and preserve our ability to provide the best care to our patients. One way to reach these officials is through the local media. Here are some tips on how to reach out to reporters, write op-eds and letters, and become a knowledgeable resource for your community…
Did Reports of Side Effects Contribute to Drop in Bone Drug Use?
(Reuters Health)—Media reports raising safety concerns about osteoporosis drugs known as bisphosphonates may have contributed to a sharp drop in their use—even though U.S. doctors and drug regulators haven’t recommended against taking them, a study suggests. Fosamax (alendronate sodium) won U.S. marketing approval in 1995. Widespread use of the drug and others like it over…
ACR launches its First Public Relations campaign
Many of us have experienced that look—confusion—when you tell someone that you work in rheumatology. It happens at dinner parties, in line at the grocery store, and during conversations on airplanes. The look can open the door to conversations about rheumatology. However, when the influential people whose decisions affect our specialty don’t know who we…
The Rheumatologist Revamps Its Website
The latest in rheumatology at your fingertips
Osteoarthritis the Focus of New Ad Campaign
Exercise and weight loss are key messages of this public education effort
Reach Out To Local Media to Promote Rheumatology
The ACR is committed to advocating on behalf of its members. This could be on Capitol Hill, by working with insurance providers, or by working with the media to promote the work of rheumatologists and rheumatology health professionals and advance the issues affecting them.